Search Results

There are 5144 results for: content related to: Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma

  1. You have free access to this content
    VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

    British Journal of Haematology

    Volume 155, Issue 2, October 2011, Pages: 190–197, Julie E. Chang, Christopher Peterson, Sangbum Choi, Jens C. Eickhoff, KyungMann Kim, David T. Yang, Leslie A. Gilbert, Eric S. Rogers, Jae E. Werndli, Michael S. Huie, Thomas A. McFarland, Michael Volk, Jules Blank, Natalie S. Callander, Walter L. Longo and Brad S. Kahl

    Article first published online : 16 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08820.x

  2. You have free access to this content
    Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine


    Volume 115, Issue 5, 1 March 2009, Pages: 1041–1048, Mar Garcia, Jorge E. Romaguera, Kedar V. Inamdar, George Z. Rassidakis and L. Jeffrey Medeiros

    Article first published online : 23 JAN 2009, DOI: 10.1002/cncr.24141

  3. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  4. You have free access to this content
    Therapeutic concepts in mantle cell lymphoma

    European Journal of Haematology

    Volume 85, Issue 5, November 2010, Pages: 371–386, Jose Rodriguez, Antonio Gutierrez, Antonia Obrador-Hevia, Silvia Fernandez de Mattos and Fernando Cabanillas

    Article first published online : 21 OCT 2010, DOI: 10.1111/j.1600-0609.2010.01515.x

  5. You have free access to this content
    Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine


    Volume 115, Issue 20, 15 October 2009, Pages: 4727–4736, Kedar V. Inamdar, Jorge E. Romaguera, Elias Drakos, Ronald J. Knoblock, Mar Garcia, Vasiliki Leventaki, L. Jeffrey Medeiros and George Z. Rassidakis

    Article first published online : 25 AUG 2009, DOI: 10.1002/cncr.24506

  6. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)


    Volume 21, Issue 4, July 2015, Pages: 469–476, A. R. Langley, A. M. Stain, A. Chan, M. McLimont, S. Chait, J. Wu, M.-C. Poon, R. Card, S. J. Israels, N. Laferriere, R. J. Klaassen, G. E. Rivard, S. Cloutier, S. Hawes, B. Feldman and V. Blanchette

    Article first published online : 24 JUN 2015, DOI: 10.1111/hae.12713

  7. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland


    K. Vepsäläinen, R. Lassila, M. Arola, P. Lähteenmäki, M. Möttönen, A. Mäkipernaa and P. Riikonen

    Article first published online : 31 MAR 2015, DOI: 10.1111/hae.12665

  8. You have free access to this content
    Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma

    British Journal of Haematology

    Volume 150, Issue 2, July 2010, Pages: 200–208, Jorge E. Romaguera, Luis E. Fayad, Lei Feng, Kimberly Hartig, Pamela Weaver, Maria Alma Rodriguez, Fredrick B. Hagemeister, Barbara Pro, Peter McLaughlin, Anas Younes, Felipe Samaniego, Andre Goy, Fernando Cabanillas, Hagop Kantarjian, Larry Kwak and Michael Wang

    Article first published online : 26 MAY 2010, DOI: 10.1111/j.1365-2141.2010.08228.x

  9. You have free access to this content
    Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma


    Volume 118, Issue 6, 15 March 2012, Pages: 1566–1573, Pei Lin, Timothy J. Dickason, Luis E. Fayad, Patrick A. Lennon, Peter Hu, Mar Garcia, Mark J. Routbort, Roberto Miranda, Xumei Wang, Wei Qiao and L. Jeffrey Medeiros

    Article first published online : 31 AUG 2011, DOI: 10.1002/cncr.26433

  10. Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma

    American Journal of Hematology

    Volume 90, Issue 6, June 2015, Pages: E111–E116, Peter J. Hosein, Jose D. Sandoval-Sus, Deborah Goodman, Alexandra Gomez Arteaga, Isildinha Reis, James Hoffman, Alexandra Stefanovic, Joseph D. Rosenblatt and Izidore S. Lossos

    Article first published online : 2 APR 2015, DOI: 10.1002/ajh.23996

  11. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study


    V. Rodriguez, M. E. Mancuso, D. Warad, C. R. M. Hay, D. M. DiMichele, L. Valentino, G. Kenet and R. Kulkarni

    Article first published online : 14 JUL 2015, DOI: 10.1111/hae.12740

  12. You have free access to this content
    Anthracycline dose intensification in adult acute lymphoblastic leukemia


    Volume 116, Issue 19, 1 October 2010, Pages: 4580–4589, Deborah Thomas, Susan O'Brien, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Sherry Pierce, Jorge Cortes and Hagop Kantarjian

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25319

  13. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator


    C. E. McCarthy, M. O'Brien, J. Andrews, J. M. Zoland, E. Macasiray, W. Wong, C. Lo, B. Glader, J. Tamaresis and M. Jeng

    Article first published online : 7 AUG 2015, DOI: 10.1111/hae.12772

  14. Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 356–365, Christopher B. Benton, Deborah A. Thomas, Hui Yang, Farhad Ravandi, Michael Rytting, Susan O'Brien, Anna R. Franklin, Gautam Borthakur, Samuel Dara, Monica Kwari, Sherry R. Pierce, Elias Jabbour, Hagop Kantarjian and Guillermo Garcia-Manero

    Article first published online : 26 JUL 2014, DOI: 10.1111/bjh.13050

  15. You have free access to this content

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Article first published online : 9 JUN 2015, DOI: 10.1002/hon.2229

  16. Rituximab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono and Maria E Suarez-Almazor

    Published Online : 20 JAN 2015, DOI: 10.1002/14651858.CD007356.pub2

  17. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis


    Volume 14, Issue 1, January 2008, Pages: 30–38, M. V. RAGNI, J. M. JOURNEYCAKE and D. J. BRAMBILLA

    Article first published online : 13 NOV 2007, DOI: 10.1111/j.1365-2516.2007.01599.x

  18. You have free access to this content
    Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

    British Journal of Haematology

    Volume 163, Issue 5, December 2013, Pages: 611–620, Yasuhiro Oki, Jason R. Westin, Francisco Vega, Hubert Chuang, Nathan Fowler, Sattva Neelapu, Fredrick B. Hagemeister, Peter McLaughlin, Larry W. Kwak, Jorge E. Romaguera, Michelle Fanale, Anas Younes, Maria Alma Rodriguez, Robert Z. Orlowski, Michael Wang, Souzanne T. Ouzounian, Felipe Samaniego and Luis Fayad

    Article first published online : 1 OCT 2013, DOI: 10.1111/bjh.12585

  19. Central venous access devices for paediatric patients with haemophilia: a single-institution experience


    Volume 15, Issue 1, January 2009, Pages: 168–174, R. TITAPIWATANAKUN, C. MOIR, R. K. PRUTHI, P. L. STAVLO, K. A. SCHMIDT and V. RODRIGUEZ

    Article first published online : 8 OCT 2008, DOI: 10.1111/j.1365-2516.2008.01906.x

  20. You have free access to this content

    Hematological Oncology

    Volume 31, Issue S1, June 2013, Pages: 201–270,

    Article first published online : 17 JUN 2013, DOI: 10.1002/hon.2059